Metabolic Disorders | Australian Biotech Company News

Home Tags Metabolic Disorders

Biotechnology

Ultrafast, Stable Insulin Developed Thanks to Some “Magic Fairy Dust” Polymer...

BioChannel - July 2, 2020

Biotechnology

Protein Discovered as Potential Treatment for Obesity

BioChannel - June 11, 2020

Biotechnology

Electrogenetic Device Allows Remote Control of Cell Signaling

BioChannel - May 28, 2020

Biotechnology

New Drug Combo May Lead to Novel and Effective Diabetes Therapy

BioChannel - February 12, 2020

Biotechnology

Glutamine Shots in Mice Reduce Body Fat Mass and Fat Cell...

BioChannel - December 20, 2019

Biotechnology

Inflammatory Disease Vaccination Strategy Targets Gut Microbiome Protein

BioChannel - December 11, 2019

Biotechnology

Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership

BioChannel - November 21, 2019

Biotechnology

Intestinal Stretch Tells Brain to Switch Off Appetite

BioChannel - November 15, 2019

Biotechnology

Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M

BioChannel - November 13, 2019

Biotechnology

Hyper-Long Telomeres Give Non-Genetically Modified Mice Longer, Healthier Lives

BioChannel - October 18, 2019

12 3 Page 1 of 3

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News